Nothing Special   »   [go: up one dir, main page]

Hsu et al., 1974 - Google Patents

Instrumented PVP-augmented antiglobulin tests

Hsu et al., 1974

Document ID
10548085724121242773
Author
Hsu T
Rosenfield R
Burkart P
Wong K
Kochwa S
Publication year
Publication venue
Vox Sanguinis

External Links

Snippet

Abstract 34 patients found to have positive direct antiglobulin tests were divided into 3 classes:(1) no evidence of active acquired hemolytic anemia (AHA);(2) active warm AHA, and (3) active cold AHA. Of 16 patients in the first category, 4 had multiple myeloma, but 10 …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/222—Platelet disorders

Similar Documents

Publication Publication Date Title
Gebel et al. Sensitization and sensitivity: defining the unsensitized patient
Fudenberg et al. Physical properties of the red cell agglutinins in acquired hemolytic anemia
Pegels et al. Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetra-acetate
Garratty Immune hemolytic anemia associated with negative routine serology
Harboe et al. Properties of various anti-γ-globulin factors in human sera
Hsu et al. Instrumented PVP-augmented antiglobulin tests
US4810632A (en) Cell surface antigen detection method
Petz Bystander immune cytolysis
Okutsu et al. Increased detection of clinically significant antibodies and decreased incidence of delayed haemolytic transfusion reaction with the indirect antiglobulin test potentiated by polyethylene glycol compared to albumin: a Japanese study
Wu et al. Heterogeneity of antibody response to human platelet transfusion.
JP2803824B2 (en) Cell surface antigen detection method
Ware et al. The use of radiolabeled and fluorescein-labeled antiglobulins in assays to predict platelet transfusion outcome
Perrault Naturally-occurring anti-M and anti-N with special case: IgG anti-N in a NN donor
Moore et al. A mouse monoclonal antibody with anti‐A,(B) specificity which agglutinates Ax cells
Von dem Borne et al. IgG4 autoantibodies against erythrocytes, without increased haemolysis: a case report
Szymanski et al. An autoanalyzer test to determine immunoglobulin class and IgG subclass of blood group antibodies
Allen Jr et al. Further observations on the Matuhasi-Ogata phenomenon
Rosenfield et al. Complement and the antiglobulin test
Cowley et al. Biotinylation modifies red cell antigens
Ingerslev et al. Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies
Fuller Monitoring HIA Alloimmunization: Analysis of HLA Alloantibodies in the Serum of Prospective Transplant Recipients
Rosner et al. The influence of dialysis in 2‐mercaptoethanol reduction of erythrocyte antibodies
Garratty Screening for RBC antibodies-what should we expect from antibody detection RBCs
Gallanagh et al. Successful engraftment in recipients of haploidentical stem cells with donor-specific antibodies: role of flow cytometric cross-match
Mollison The effect of isoantibodies on red‐cell survival